Clinical Resource for Healthcare Providers
Precision pharmacogenomics at the point of care. The myDNAid PGx card puts critical drug-gene interaction data in your patients' hands—ready for immediate clinical decision-making.
Instant access to critical contraindications in emergency situations:
Optimize medication selection and dosing for:
Prevent life-threatening toxicities from chemotherapy:
Optimize antimicrobial therapy:
Patient presents their myDNAid PGx card during consultation or emergency visit.
Scan the QR code on the front of the card using any smartphone. This directs you to our secure decrypt portal.
Enter your contact information (phone number) to request access. A 6-digit OTP is sent via SMS to your phone number.
The patient receives SMS notifications that a decryption request was made and by which phone number. You then enter the OTP you received to decrypt the patient's PGx data.
Once authorized, you instantly see the patient's complete PGx profile including:
The patient receives SMS notifications confirming that you accessed their record, ensuring full transparency and audit compliance.
Clinical Context
Emergency Alerts
Complete drug-gene interaction data organized by therapeutic area:
Anesthesia & Emergency
CYP2D6, CYP2C19, RYR1, CACNA1S, G6PD
Cardiovascular
CYP2C9, VKORC1, SLCO1B1, CYP2D6, ADRB1
Pain Management
CYP2D6, CYP2C9, CYP2C19, COMT, OPRM1
Psychiatry & Neurology
CYP2D6, CYP2C19, CYP1A2, MTHFR, SLC6A4, HTR2A, HLA-B*15:02, HLA-A*31:01
Infectious Diseases
CYP2B6, HLA-B*57:01, CYP2C19
Total Genes
19 critical pharmacogenes
Poor Metabolizer (PM)
Significantly reduced or absent enzyme activity. Risk of drug accumulation and toxicity. Consider dose reduction or alternative medication.
Intermediate Metabolizer (IM)
Reduced enzyme activity. May require dose adjustment. Monitor for adverse effects.
Normal Metabolizer (NM)
Standard enzyme activity. Standard dosing appropriate.
Rapid/Ultra-rapid Metabolizer (RM/UM)
Increased enzyme activity. Risk of therapeutic failure due to rapid drug clearance. Consider alternative medication or dose increase.
⚠️ Avoid Drug
Drug is contraindicated due to high risk of adverse reaction or lack of efficacy. Use safe alternatives listed.
💊 Dose Adjustment
Drug can be used but requires dose modification based on metabolizer status. Follow CPIC guidelines.
🔬 Alternative Medication
Safer or more effective alternatives are available. Consider switching to recommended alternatives.
📊 Monitor Closely
Drug can be used with standard dosing but requires enhanced therapeutic drug monitoring or clinical monitoring.
The myDNAid PGx card focuses on 19 critical pharmacogenes for immediate medication safety. However, patients' whole genomes contain over 20,000 genes with clinical relevance across multiple conditions.
Comprehensive clinical genetic screening for:
Requires genetic counseling and doctor's referral
Complete genomic analysis including:
Requires genetic counseling and doctor's referral
💡 Re-Analysis for Existing PGx Patients
Patients who already have PGx data with us can get comprehensive re-analysis of all 10,000+ remaining genes for USD $100 - $150 per condition, depending on the number of genes involved.
For inquiries about available tests and further explanations, contact us on:
inquiries@nextgenmolecularlab.com
Location
Roslyn Riviera Mall, 3rd Floor
Limuru Rd, Nairobi
Clin & Gmx require doctor's referral. PGx is available direct-to-consumer.